Factors associated with foreign body infection in methicillin-resistant Staphylococcus aureus bacteremia

被引:1
|
作者
Bouiller, Kevin [1 ,2 ]
Jacko, Natasia F. [1 ]
Shumaker, Margot J. [1 ]
Talbot, Brooke M. [3 ]
Read, Timothy D. [3 ]
David, Michael Z. [1 ]
机构
[1] Univ Penn, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA
[2] Univ Franche Comte, CHU Besancon, Dept Infect & Trop Dis, UMR CNRS 6249 Chrono Environm, Besancon, France
[3] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
Staphylococcus aureus; biofilm; foreign bodies; methicillin resistance; bacteremia; EUROPEAN ASSOCIATION; CASE-DEFINITION; BIOFILM; COLLABORATION; EPIDEMIOLOGY; MANAGEMENT; DIAGNOSIS; DISEASES; SOCIETY; PLATES;
D O I
10.3389/fimmu.2024.1335867
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: We aimed to compare patient characteristics, MRSA sequence types, and biofilm production of MRSA strains that did and did not cause a foreign body infection in patients with MRSA bloodstream infections (BSI) Methods: All adult patients with MRSA BSI hospitalized in two hospitals were identified by clinical microbiology laboratory surveillance. Only patients who had at least one implanted foreign body during the episode of BSI were included. Results: In July 2018 - March 2022, of 423 patients identified with MRSA BSI, 118 (28%) had >= 1 foreign body. Among them, 51 (43%) had one or more foreign body infections. In multivariable analysis, factors associated with foreign body infection were history of MRSA infection in the last year (OR=4.7 [1.4-15.5], p=0.012) community-associated BSI (OR=68.1 [4.2-1114.3], p=0.003); surgical site infection as source of infection (OR=11.8 [2-70.4], p=0.007); presence of more than one foreign body (OR=3.4 [1.1-10.7], p=0.033); interval between foreign body implantation and infection <18 months (OR=3.3 [1.1-10], p=0.031); and positive blood culture >= 48h (OR=16.7 [4.3-65.7], p<0.001). The most prevalent sequence type was ST8 (39%), followed by ST5 (29%), and ST105 (20%) with no significant difference between patients with or without foreign body infection. Only 39% of MRSA isolates formed a moderate/strong biofilm. No significant difference was observed between patients with foreign body infection and those without foreign body infection. In multivariable analysis, subjects infected with a MRSA isolate producing moderate/strong in vitro biofilm were more likely to have a history of MRSA infection in the last year (OR=3.41 [1.23-9.43]), interval between foreign body implantation and MRSA BSI <18 months (OR=3.1 [1.05-9.2]) and ST8 (OR=10.64 [2-57.3]). Conclusion: Most factors associated with foreign body infection in MRSA BSI were also characteristic of persistent infections. Biofilm-forming isolates were not associated with a higher risk of foreign-body infection but appeared to be associated with MRSA genetic lineage, especially ST8.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Foreign body infection of methicillin-resistant Staphylococcus aureus in a sternal wound
    Kiyosawa, T
    Demitsu, T
    Yamamoto, N
    Kikuchi, M
    Nito, M
    Haga, Y
    Chiku, A
    Nakayama, Y
    ANNALS OF PLASTIC SURGERY, 2000, 45 (03) : 339 - 340
  • [2] Risk Factors Associated with Methicillin-resistant Staphylococcus aureus Infection in Children
    Senthilkumar, Kandasamy
    Biswal, Niranjan
    Sistla, Sujatha
    INDIAN PEDIATRICS, 2015, 52 (01) : 31 - 33
  • [3] Colonization and infection with methicillin-resistant Staphylococcus aureus: Associated factors and eradication
    Asensio, A
    Guerrero, A
    Quereda, C
    Lizan, M
    MartinezFerrer, M
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1996, 17 (01): : 20 - 28
  • [4] Risk factors associated with Methicillin-resistant Staphylococcus aureus infection in children
    Kandasamy Senthilkumar
    Niranjan Biswal
    Sujatha Sistla
    Indian Pediatrics, 2015, 52 : 31 - 33
  • [5] METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS BACTEREMIA
    MCDONALD, M
    HURSE, A
    SIM, KN
    MEDICAL JOURNAL OF AUSTRALIA, 1981, 2 (04) : 191 - 194
  • [6] Management of methicillin-resistant Staphylococcus aureus bacteremia
    Cosgrove, Sara E.
    Fowler, Vance G., Jr.
    CLINICAL INFECTIOUS DISEASES, 2008, 46 : S386 - S393
  • [7] Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
    Choo, Eun Ju
    Chambers, Henry F.
    INFECTION AND CHEMOTHERAPY, 2016, 48 (04): : 267 - 273
  • [8] Methicillin-Resistant Staphylococcus aureus Bacteremia and Pneumonia
    Ganesan, Anuradha
    DM DISEASE-A-MONTH, 2008, 54 (12): : 787 - 792
  • [9] RISK FACTORS ASSOCIATED WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) BACTEREMIA IN THE UNITED STATES
    Pawar, A. M.
    Willey, C. J.
    Caffrey, A. R.
    VALUE IN HEALTH, 2014, 17 (03) : A9 - A9
  • [10] Methicillin-resistant/methicillin-sensitive Staphylococcus aureus bacteremia
    Austin, TW
    Austin, MA
    Coleman, B
    SAUDI MEDICAL JOURNAL, 2003, 24 (03) : 256 - 260